Big, fat demand for weight-loss drugs fuels Eli Lilly stock surge — as market cap hits $1.2 trillion
Eli Lilly stock hit a record high Thursday thanks to a stronger-than-expected earnings report fueled by sales of weight loss drugs Monjuaro and Zepbound.
Read original article on New York Post →Related news
-
Moment hero worker tries to stop train knifeman with frying pan as he 'attempted to murder 10 passengers' is shown in court
Crime & Justice
Crime
United Kingdom
-
Ram raid gang jailed for smashing their way into West End's Yves Saint Laurent before stealing £30,000 worth of luxury handbags in night heist
Crime & Justice
Crime
United Kingdom
- Deport Immigrants? Oh Yes. But Not This Guy. Politics Government United States
-
Trump's 'human printer' Natalie Harp, 35, ditches her desk to work from president's private dining room as election worries grip White House
Politics
Government
United States
-
Met refers itself to police watchdog over letter passed to Meghan about Thomas Markle in 2019
Crime & Justice
Law Enforcement
United Kingdom
-
California High Speed Rail authority names new interim CEO after former chief’s abrupt resignation
Politics
Local Government
United States
-
The world’s largest bats are shrinking — and hunters are to blame: study
Environment & Nature
Climate
-
England's best-performing - and most beleaguered - A&Es, where more than one in four patients endure waits of over 12 hours... as deaths linked to overcrowded emergency departments surge 850 per cent in a decade
Politics
Government
England